Inventor

WEBER ANN E

US49 patents

⚠️ This page may combine multiple inventors who share the name “WEBER ANN E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

WEBER ANN E

MERCK & CO INC

Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

Substituted sulfonamides as selective β-3 agonists for the treatment of diabetes and obesity

Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity

Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity

Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and tetrahydrotrioazolo (4, 3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

Fused piperidine substituted arylsulfonamides as β3-agonists

Selective β3 agonists for the treatment of diabetes and obesity

Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity

Oxadiazole benzenesulfonamides as selective β3 Agonist for the treatment of Diabetes and Obesity

Amide derivatives as β 3 agonists

Thiazole benzenesulfonamides as β3 agonists for treatment of diabetes and obesity

3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes

Dipeptidyl peptidase inhibitors for the treatment of diabetes

Cyclic renin inhibitors containing 2-substituted (3S,4S)-4-amino-5-cyclohexyl-3-hydroxy pentanoic acid, 2-substituted (3S,4S)-5-cyclohexyl-3,4-di-hydroxy pentanoic acid or 2-substituted (4S,5S)-5-amino-6-cyclohexyl-4-hydroxyhexanoic acid or its analogs

β-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

Cyclic renin inhibitors containing 3(S)-amino-4-cyclohexyl-2(R)-hydroxy-butanoic acid or 4-cyclo-hexyl-(2R, 3S)-dihydroxybutanoic acid or related analogs

Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

Dipeptidyl peptidase inhibitors for the treatment of diabetes

3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

Hexahydrodiazepinones as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

Fused triazole derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

MERCK SHARP & DOHME

Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

2′-alkynyl substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases

Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes

Dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

Aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes

Substituted 5,6,7,8-tetrahydropyrido[4,3-D]pyrimidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

Substitued [1,2,4]triazolo[1,5-a]pyrazines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

Bicyclic pyrimidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes

Cyclohexylalanine derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

BIFTU TESFAYE

Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

Heterocyclic compounds as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

EDMONDSON SCOTT D

Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of diabetes

Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of type 2 diabetes

COX JASON M

Substituted aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes